1. Clinical trials go global -- 2. The placebo control -- 3. Growing the pharma monolith -- 4. Uncaging the guinea pig -- 5. HIV and the second-rate solution -- 6. South Africa : drug trials and AIDS denialism -- 7. Outsourcing to India : the one billion body politic -- 8. Calib…
Reveals the unethical drug testing practices of the multinational pharmaceutical industry. Based on research and reporting from Africa and Asia, the author shows how the pharmaceutical industry is using testing procedures in the global South that would cause scandals in the deve…
Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant r…
Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant r…
Since the initial publication of Development and Evaluation Drugs from Laboratory through Licensure to Market in 1993, many changes have occurred in biomedicine, biotechnology, pharmaceutical science and technology, and drug evaluation systems. Updated and expanded, this second …
Since its initial publication in 1993, Development and Evaluation of Drugs from Laboratory through Licensure to Market has been used as a textbook and reference for scientists in biomedical research, industry, and regulatory agencies. Updated and expanded, this second edition ex…
This book guides the reader through FDA regulation guidelines and outlines a comprehensive strategy for cost reduction in regulatory affairs and compliance. This book explains six strategies to cost-effectively comply with FDA regulations while maintaining product safety and imp…